9
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome

, , , , &
Pages 311-315 | Published online: 05 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Seyit Temel Ceyhan, Umit Goktolga, Emre Karasahin, İbrahim Alanbay & Namik Kemal Duru. (2008) Continuous vaginal and bilateral thoracic fluid drainage for management of severe ovarian hyperstimulation syndrome. Gynecological Endocrinology 24:9, pages 505-507.
Read now
L. Cobellis, E. Pecori, L. Stradella, E. De Lucia, E. M. Messalli & G. Cobellis. (2003) Ovarian hyperstimulation syndrome: distinction between local and systemic disease. Gynecological Endocrinology 17:2, pages 95-99.
Read now
L. Cobellis, E. Pecori, E. De Lucia, G. Pierno, L. Stradella, F. M. Severi & F. Petraglia. (2001) Regression of ovarian enlargement in pharmacological ovulation induction. Gynecological Endocrinology 15:3, pages 239-242.
Read now

Articles from other publishers (11)

Dantam Hymavathi DeviDr.Dr.. (2021) LOW DOSE HCG IN PREVENTING OHSS IN HIGH-RISK WOMEN. PARIPEX INDIAN JOURNAL OF RESEARCH, pages 7-8.
Crossref
Kenzo Kosaka, Hiroshi Fujiwara, Shinya Yoshioka & Shingo Fujii. (2007) Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome. Human Reproduction 22:6, pages 1647-1651.
Crossref
Dolors Manau, Francisco Fábregues, Joana Peñarrubia, Montserrat Creus, Francisco Carmona, Gemma Casals, Wladimiro Jiménez & Juan Balasch. (2007) Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF. Human Reproduction 22:3, pages 669-675.
Crossref
Geeta Nargund, Lee Hutchison, Rex Scaramuzzi & Stuart Campbell. (2007) Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reproductive BioMedicine Online 14:6, pages 682-685.
Crossref
Nick S. MacklonRichard L. StoufferLinda C. Giudice & Bart C. J. M. Fauser. (2006) The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization. Endocrine Reviews 27:2, pages 170-207.
Crossref
ELI GEVA & ROBERT B. JAFFE. 2004. The Ovary. The Ovary 305 317 .
Ralf Einspanier, Martin Schönfelder, Karin Müller, Miodrag Stojkovic, Michaela Kosmann, Eckhard Wolf & Dieter Schams. (2002) Expression of the vascular endothelial growth factor and its receptors and effects of VEGF during in vitro maturation of bovine cumulus‐oocyte complexes (COC). Molecular Reproduction and Development 62:1, pages 29-36.
Crossref
Botros Rizk. 2009. Ovarian Hyperstimulation Syndrome. Ovarian Hyperstimulation Syndrome 119 129 .
Botros Rizk. 2009. Ovarian Hyperstimulation Syndrome. Ovarian Hyperstimulation Syndrome 43 78 .
Napoleone Ferrara. (2000) VEGF: an update on biological and therapeutic aspects. Current Opinion in Biotechnology 11:6, pages 617-624.
Crossref
Eli Geva & Robert B Jaffe. (2000) Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and Sterility 74:3, pages 429-438.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.